Acronym
GlycoDelete-ADC
Code
F2024/IOF-StarTT/040
Duration
31 December 2024 → 30 June 2026
Funding
Regional and community funding: Industrial Research Fund
Promotor
Research disciplines
-
Medical and health sciences
- Cancer therapy
-
Engineering and technology
- Medical molecular engineering of nucleic acids and proteins
- Other biotechnology, bio-engineering and biosystem engineering not elsewhere classified
Keywords
Immunotherapy
Cancer Therapy
Antibody-drug conjugates
Conjugation technology
Project description